179 related articles for article (PubMed ID: 33863532)
1. The therapeutic effects of ginkgolides in Guillain-Barré syndrome and experimental autoimmune neuritis.
Li C; Liu S; Aerqin Q; Shen D; Wu X; Liu K
J Clin Neurosci; 2021 May; 87():44-49. PubMed ID: 33863532
[TBL] [Abstract][Full Text] [Related]
2. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
3. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis.
Bao L; Lindgren JU; Zhu Yu; Ljunggren HG; Zhu J
Neurobiol Dis; 2003 Feb; 12(1):73-81. PubMed ID: 12609491
[TBL] [Abstract][Full Text] [Related]
4. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
Bao L; Lindgren JU; van der Meide P; Zhu Sw; Ljunggren HG; Zhu J
Brain Pathol; 2002 Oct; 12(4):420-9. PubMed ID: 12408228
[TBL] [Abstract][Full Text] [Related]
5. Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?
Wu X; Wang J; Liu K; Zhu J; Zhang HL
Expert Opin Ther Targets; 2016; 20(2):209-22. PubMed ID: 26357850
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
7. Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
Jin T; Yu H; Wang D; Zhang H; Zhang B; Quezada HC; Zhu J; Zhu W
Immunol Lett; 2016 Mar; 171():15-25. PubMed ID: 26791957
[TBL] [Abstract][Full Text] [Related]
8. Can IFN-γ be a therapeutic target in Guillain-Barré syndrome?
Zhang HL; Wu L; Wu X; Zhu J
Expert Opin Ther Targets; 2014 Apr; 18(4):355-63. PubMed ID: 24479493
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen.
Yu S; Chen Z; Mix E; Zhu SW; Winblad B; Ljunggren HG; Zhu J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):614-22. PubMed ID: 12125740
[TBL] [Abstract][Full Text] [Related]
11. The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
Jiao H; Ren H
Drug Des Devel Ther; 2018; 12():3817-3824. PubMed ID: 30464413
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokines in Guillain-Barré syndrome.
Lu MO; Zhu J
J Neurol; 2011 Apr; 258(4):533-48. PubMed ID: 21104265
[TBL] [Abstract][Full Text] [Related]
13. Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis.
Liu S; Liu Y; Xiao Z; Pan S; Gong Q; Lu Z
Brain Behav; 2019 Dec; 9(12):e01478. PubMed ID: 31742934
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation.
Xie Y; Han R; Li Y; Li W; Zhang S; Wu Y; Zhao Y; Liu R; Wu J; Jiang W; Chen X
J Neuroinflammation; 2024 Mar; 21(1):73. PubMed ID: 38528529
[TBL] [Abstract][Full Text] [Related]
15. The dynamic expression of canonical Wnt/β-catenin signalling pathway in the pathologic process of experimental autoimmune neuritis.
Liu Y; Liu S; Pan S; Gong Q; Yao J; Lu Z
Int J Neurosci; 2020 Nov; 130(11):1109-1117. PubMed ID: 32009498
[No Abstract] [Full Text] [Related]
16. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
17. M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response.
Du T; Yang CL; Ge MR; Liu Y; Zhang P; Li H; Li XL; Li T; Liu YD; Dou YC; Yang B; Duan RS
Front Immunol; 2020; 11():1603. PubMed ID: 32793234
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response.
Zhang HL; Azimullah S; Zheng XY; Wang XK; Amir N; Mensah-Brown EP; Al Shamsi M; Shahin A; Press R; Zhu J; Adem A
J Neuroimmunol; 2012 May; 246(1-2):18-26. PubMed ID: 22445739
[TBL] [Abstract][Full Text] [Related]
19. Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Xia RH; Yosef N; Ubogu EE
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):388-98. PubMed ID: 20500551
[TBL] [Abstract][Full Text] [Related]
20. Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis.
Shen D; Chu F; Lang Y; Geng Y; Zheng X; Zhu J; Liu K
Mediators Inflamm; 2018; 2018():4286364. PubMed ID: 29853789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
